Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Altimmune (ALT) just unveiled an announcement.
David J. Drutz, M.D. has announced he will not seek re-election to the Board of Directors for Altimmune, Inc. at the upcoming 2024 Annual Meeting of Shareholders, although he will serve until then. His departure is not related to any operational, policy, or practice disagreements with the Company, and the Board has expressed gratitude for his contributions during his tenure.
See more insights into ALT stock on TipRanks’ Stock Analysis page.